human | Q5 |
P496 | ORCID iD | 0000-0002-1555-1089 |
P108 | employer | University of Alberta | Q640694 |
P735 | given name | Constantine | Q19327451 |
Constantine | Q19327451 | ||
P106 | occupation | researcher | Q1650915 |
P21 | sex or gender | male | Q6581097 |
Q45933460 | A case-control study of single-pass albumin dialysis for acetaminophen-induced acute liver failure. |
Q37847246 | A comparison of early versus late initiation of renal replacement therapy in critically ill patients with acute kidney injury: a systematic review and meta-analysis. |
Q50294753 | A multicenter retrospective cohort analysis of therapeutic hypothermia in acute liver failure |
Q33785082 | A randomized trial of supplemental parenteral nutrition in underweight and overweight critically ill patients: the TOP-UP pilot trial |
Q94388937 | A22 LIVER TYPE FATTY ACID BINDING PROTEIN (FABP1) LEVELS IMPROVE PERFORMANCE OF PROGNOSTIC MODELS IN ACETAMINOPHEN INDUCED ACUTE LIVER FAILURE |
Q94390118 | A322 ALBUMIN MODIFIED BODY MASS INDEX FOR THE ASSESSMENT OF CIRRHOTIC PATIENTS UNDERGOING ORTHOTOPIC LIVER TRANSPLANT |
Q94390603 | A73 SURVIVAL PREDICTORS IN PATIENTS UNDERGOING LIVER TRANSPLANT FOR NON-ALCOHOLIC STEATOHEPATITIS: A POPULATION-BASED COHORT STUDY |
Q89154325 | Absolute quantitation of acetaminophen-modified human serum albumin in acute liver failure patients by liquid chromatography/tandem mass spectrometry |
Q46495604 | Acetaminophen-induced acute liver failure treated with single-pass albumin dialysis: report of a case |
Q38031402 | Acquired liver injury in the intensive care unit. |
Q38593649 | Acute Kidney Injury in Cirrhosis. |
Q88128478 | Acute Liver Failure from Tumor Necrosis Factor-α Antagonists: Report of Four Cases and Literature Review |
Q91193644 | Acute kidney injury in cirrhosis: implications for liver transplantation |
Q39107405 | Acute liver failure: An up-to-date approach |
Q38720047 | Acute liver injury and acute liver failure from mushroom poisoning in North America. |
Q52566910 | Acute-on-Chronic Liver Failure: Getting ready for prime-time. |
Q38186962 | Advances in management and prognostication in critically ill cirrhotic patients. |
Q41471248 | Appropriate and timely antimicrobial therapy in cirrhotic patients with spontaneous bacterial peritonitis-associated septic shock: a retrospective cohort study |
Q80764514 | Arterial ammonia and clinical risk factors for encephalopathy and intracranial hypertension in acute liver failure |
Q83100974 | Association between implementation of an intensivist-led medical emergency team and mortality |
Q46275318 | Bacteremia, APACHE II and need for renal replacement therapy are independent predictors of mortality in critically ill transplanted patients with cirrhosis |
Q43892582 | Bacteremia, acute physiology and chronic health evaluation II and modified end stage liver disease are independent predictors of mortality in critically ill nontransplanted patients with acute on chronic liver failure |
Q31385252 | Beta-lactones as a new class of cysteine proteinase inhibitors: inhibition of hepatitis A virus 3C proteinase by N-Cbz-serine beta-lactone. |
Q90961908 | BiMM forest: A random forest method for modeling clustered and longitudinal binary outcomes |
Q83535621 | Bloodstream infection after elective liver transplantation is associated with increased mortality in patients with cirrhosis |
Q37612383 | Character and temporal evolution of apoptosis in acetaminophen-induced acute liver failure*. |
Q88515341 | Class III obesity is a risk factor for the development of acute-on-chronic liver failure in patients with decompensated cirrhosis |
Q40320559 | Clinical Impact of Portal Vein Thrombosis Prior to Liver Transplantation: A Retrospective Cohort Study. |
Q40621142 | Clinical and microbiological characteristics associated with mortality in spontaneous bacterial peritonitis: a multicenter cohort study. |
Q88663297 | Coagulation Defects in the Cirrhotic Patient Undergoing Liver Transplantation |
Q80089044 | Comment on Camus et al.: "Molecular adsorbent recirculating system dialysis in patients with acute liver failure who are assessed for liver transplantation" |
Q45073698 | Comment on: MARS System Effectively Replaces Hepatic Function in Severe Acute Liver Failure |
Q41712463 | Comorbidities have a limited impact on post-transplant survival in carefully selected cirrhotic patients: a population-based cohort study. |
Q48145452 | Continuous renal replacement therapy is associated with reduced serum ammonia levels and mortality in acute liver failure |
Q45035130 | Corrigendum to "Management of the critically ill patients with cirrhosis: A multidisciplinary perspective". |
Q39422269 | Critical Care management of the cirrhotic patient awaiting liver transplant in the Intensive Care Unit |
Q92910313 | Critical care considerations in the management of acute-on-chronic liver failure |
Q38875447 | Current Evidence for Extracorporeal Liver Support Systems in Acute Liver Failure and Acute-on-Chronic Liver Failure. |
Q55443429 | Determining late predictors of outcome for acetaminophen- induced acute liver failure using classification and regression tree modeling analysis. |
Q36016877 | Development and Pilot of a Checklist for Management of Acute Liver Failure in the Intensive Care Unit |
Q90939496 | Dynamic Prognostication in Critically Ill Cirrhotic Patients With Multiorgan Failure in ICUs in Europe and North America: A Multicenter Analysis |
Q33361966 | Effect of capecitabine on mean corpuscular volume in patients with metastatic breast cancer. |
Q91026762 | Effect of the clinical course of acute-on-chronic liver failure prior to liver transplantation on post-transplant survival |
Q34381441 | Effects of antimicrobial prophylaxis and blood stream infections in patients with acute liver failure: a retrospective cohort study. |
Q37656786 | Elevated FABP1 serum levels are associated with poorer survival in acetaminophen-induced acute liver failure |
Q89992642 | Elevated Serum Liver-Type Fatty Acid Binding Protein Levels in Non-acetaminophen Acute Liver Failure Patients with Organ Dysfunction |
Q93372918 | Emerging Role of Extracorporeal Support in Acute and Acute-on-Chronic Liver Failure: Recent Developments |
Q93190422 | Graft Dysfunction and Management in Liver Transplantation |
Q33433133 | HBV-Associated Acute Liver Failure After Immunosuppression and Risk of Death |
Q45019681 | High volume plasma exchange in acute liver failure: Dampening the inflammatory cascade? |
Q95534956 | In reply |
Q35024185 | Increased health services use by severely obese patients undergoing emergency surgery: a retrospective cohort study. |
Q45932604 | Intracranial pressure monitoring in acute liver failure: a retrospective cohort study. |
Q92216708 | Intraoperative continuous renal replacement therapy during liver transplantation: a pilot randomized-controlled trial (INCEPTION) |
Q64884983 | Is palliative care appropriate in the liver transplant candidate? |
Q92066189 | Lactate and number of organ failures predict intensive care unit mortality in patients with acute-on-chronic liver failure |
Q85289783 | Letter: what else can improve survival in cirrhotic patients with spontaneous bacterial peritonitis and associated septic shock? Authors' reply |
Q97591143 | Leucocyte ratios are biomarkers of mortality in patients with acute decompensation of cirrhosis and acute-on-chronic liver failure |
Q48217601 | Liver transplant in acute-on-chronic liver failure: Evaluating the impact of organ dysfunction |
Q45933490 | Liver transplantation in the critically ill: a Canadian collaboration. |
Q96647760 | Long-term outcomes of patients undergoing liver transplantation for acute-on-chronic liver failure |
Q50932851 | MARS in acute-on-chronic liver failure. |
Q47904256 | Management of Cerebral Edema in Acute Liver Failure. |
Q30278436 | Management of the critically ill patient with cirrhosis: A multidisciplinary perspective |
Q93141339 | Managing the patient with acute liver failure |
Q84230798 | Massive upper gastrointestinal hemorrhage caused by an arterio-esophageal fistula |
Q43090483 | Medical and psychiatric outcomes for patients transplanted for acetaminophen-induced acute liver failure: a case-control study. |
Q90166360 | Metabolic support in the critically ill: a consensus of 19 |
Q36041222 | Outcomes and complications of intracranial pressure monitoring in acute liver failure: a retrospective cohort study. |
Q91997626 | Pathophysiology of Acute Liver Failure |
Q92599697 | Patients With Acute on Chronic Liver Failure Grade 3 Have Greater 14-Day Waitlist Mortality Than Status-1a Patients |
Q37092640 | Postoperative delirium in the intensive care unit predicts worse outcomes in liver transplant recipients. |
Q35647592 | Postoperative resource utilization and survival among liver transplant recipients with Model for End-stage Liver Disease score ≥ 40: A retrospective cohort study |
Q59322992 | Postoperative resource utilization and survival among liver transplant recipients with Model for End-stage Liver Disease score ≥40: a retrospective cohort study |
Q64108734 | Predicting daily outcomes in acetaminophen-induced acute liver failure patients with machine learning techniques |
Q57815477 | Predicting in-hospital mortality in pneumonia-associated septic shock patients using a classification and regression tree: a nested cohort study |
Q35462783 | Predicting outcome on admission and post-admission for acetaminophen-induced acute liver failure using classification and regression tree models |
Q46063085 | Predictors of bacteraemia and mortality in patients with acute liver failure. |
Q88219229 | Prognostication of critically ill patients with acute-on-chronic liver failure using the Chronic Liver Failure-Sequential Organ Failure Assessment: A Canadian retrospective study |
Q87733533 | REPLY |
Q36098647 | Relevance of New Definitions to Incidence and Prognosis of Acute Kidney Injury in Hospitalized Patients with Cirrhosis: A Retrospective Population-Based Cohort Study |
Q95422689 | Reply |
Q42428741 | Reply: To PMID 25308108. |
Q89053660 | Respiratory Complications Before and After Liver Transplant |
Q46453550 | Respiratory rate at intensive care unit discharge after liver transplant is an independent risk factor for intensive care unit readmission within the same hospital stay: a nested case-control study |
Q37798751 | Review article: Renal support in critical illness. |
Q39175965 | Sarcopenia is a predictor of outcomes in very elderly patients undergoing emergency surgery |
Q89535233 | Serum osmolality, cerebrospinal fluid specific gravity and overt hepatic encephalopathy severity in patients with liver failure |
Q90366646 | Significant lung injury and its prognostic significance in acute liver failure: A cohort analysis |
Q91448263 | The Hepatokine TSK does not affect brown fat thermogenic capacity, body weight gain, and glucose homeostasis |
Q42370987 | The association between FABP7 serum levels with survival and neurological complications in acetaminophen-induced acute liver failure: a nested case-control study |
Q92482666 | The hepatokine Tsukushi is released in response to NAFLD and impacts cholesterol homeostasis |
Q90392691 | The impact of cirrhosis in patients undergoing cardiac surgery: a retrospective observational cohort study |
Q40582403 | The impact of delayed biliary decompression and anti-microbial therapy in 260 patients with cholangitis-associated septic shock. |
Q92332363 | The impact of delayed source control and antimicrobial therapy in 196 patients with cholecystitis-associated septic shock: a cohort analysis |
Q44877545 | The impact of obesity in cirrhotic patients with septic shock: a retrospective cohort study |
Q45597292 | The incidence of potential missed organ donors in intensive care units and emergency rooms: a retrospective cohort |
Q37082406 | Therapeutic hypothermia in acute liver failure: a multicenter retrospective cohort analysis. |
Search more.